Translatomics for calibrated ribo-seq, Alzheimer and leukemia

Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Tomuro et al. address contamination from rRNA and the inability to accurately measure the number of ribosomes on transcripts in Ribo-Seq libraries. Filomena et al. analyze two RNA-seq datasets, focusing on the […]

Translatomics for fasting, microproteins and lychee

Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Yang et al. discovered how translatome remodelling happens in hepatocytes during fasting, Vieira de Souza et al. uncovers the reasons why many short ORFs that are found by […]

Translatomics for mRNA modifications, elongation and hypoxia

Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Gong et al. and Liu et al. investigated the role of the ac4c modification on both eEF1A2 and eEF2 in nasopharyngeal and hepatocellular carcinoma respectively, while […]

Translatomics for rare codons, neuron and grape

Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Sejour et al suggested that the slowly decoded rare codons were evolutionary leftovers that have no role in translation efficiency. Francisco-Velilla et al unveiled the ability of RNA-binding […]

Translatomics for tRNA, stop codon readthrough and IRE

Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, El-Hachem N. et al. find that valine aminoacyl-tRNA synthetase re-sensitized RES melanoma cells to BRAF inhibition (vemurafenib) in a dose-dependent manner, Romero Romero ML et al. hypothesize that […]